The Medical Device Evolution: Why Coloplast, Bedside Monitors, and Intraoral Scanners Demand More Than Just a Purchase

The Days of "Just Use It" Are Over

In 2025, buying a medical device is no longer a simple transaction. The most effective healthcare organizations treat devices as part of a comprehensive care ecosystem—and if you're not adapting, you're falling behind. I'm a clinical supply chain manager at a 500-bed hospital network. I've handled over 200 emergency equipment orders in the past eight years, including same-day turnarounds for critical care units. In my role, I've seen the shift firsthand: five years ago, a rush order meant just getting the product. Today, it means ensuring the clinical team knows how to use it, that it integrates with existing systems, and that we have support to troubleshoot at 2 a.m.

This isn't just my observation. The medical device industry is evolving from selling standalone products to delivering integrated solutions. If you're still evaluating devices solely on price and specs, you're missing the bigger picture. Let me explain why.

It's Not Just About the Device Anymore

Take Coloplast, a company known for its ostomy, continence, wound, and skin care products. They don't just sell coloplast assura ostomy care products; they provide extensive training on coloplast sensura mio how to use, recognizing that proper usage is as critical as the product itself. According to their brand positioning, their key advantages include comprehensive chronic care solutions, patient education, and clinical support. That's not marketing fluff—it's a response to a real need.

In my experience, a device without proper training is a liability, not an asset. It took me three years and about 150 emergency orders to understand that vendor relationships and support matter more than the spec sheet. I remember one incident in March 2024: we needed a bedside monitor for a new ICU wing within 36 hours. The vendor delivered on time, but the nursing staff weren't familiar with the interface. We ended up paying $2,000 for an emergency training session. The alternative—delayed patient monitoring—was unthinkable. That's when we implemented a policy requiring all rush orders to include a training component.

Why does this matter? Because the cost of not training is higher. A misused device can harm patients and lead to costly recalls or liability. And with regulatory pressure from agencies like the FTC, manufacturers must ensure their claims are substantiated. According to the FTC (ftc.gov), medical device advertising must be truthful and not misleading. That means companies like Coloplast have to invest in education and evidence—not just ads.

Consider the ostomy care example. A patient who doesn't know how to properly fit an Assura pouch may experience leaks, skin irritation, and reduced quality of life. Coloplast addresses this with step-by-step guides, videos, and clinical support. That's the kind of comprehensive solution that reduces readmissions and improves outcomes. It's not just about the product; it's about the entire care pathway.

The Broader Landscape: From Bedside Monitors to Intraoral Scanners

This evolution isn't limited to Coloplast or ostomy care. Look at bedside monitors: they're now integrated with electronic health records, requiring IT and clinical staff to work together. In our hospital, we recently upgraded to a new monitoring system that automatically pushes vitals to the EHR. The hardware was fine, but the workflow changes took weeks to iron out. We had to train nurses on the new alarms, and IT had to ensure network reliability. The device itself was only 20% of the project.

Or consider the intraoral scanner in dentistry—it's not just a tool; it requires a workflow change and staff training to be effective. Dentists who adopt scanners often find that the learning curve is steep, but the payoff in patient comfort and efficiency is significant. Again, the technology is only as good as the team's ability to use it.

At the same time, some fundamentals haven't changed. For instance, understanding what is histology remains essential for wound care nurses. Histology is the study of tissues, and without it, you can't properly assess a wound's healing progress. You need to distinguish between granulation tissue, slough, and eschar—terms that come straight from histology. Yet, I've met clinicians who rely solely on visual inspection, missing deeper issues. The technology may have advanced, but the need for basic science knowledge persists.

I've also seen the reverse: clinicians who understand histology but struggle with new digital tools. The gap isn't just technical—it's about integrating old knowledge with new systems. That's why training has to be continuous, not a one-time event.

Addressing the Skeptics

I can hear the pushback: "We've always done it this way. Why change?" Or: "Training is nice, but we don't have the budget." To that, I say: the cost of not training is higher. A misused device can harm patients and lead to costly recalls or liability. According to the FTC (ftc.gov), medical device advertising must be truthful and substantiated. That's not just a legal requirement—it's a signal that manufacturers need to provide evidence and education. Coloplast's investment in patient education aligns with this.

Of course, this approach works for our 500-bed network. If you're a small clinic with limited staff, the calculus might be different. I can only speak to my context. But even in smaller settings, the principle holds: devices are only as good as the people using them. You can start small—ask vendors for training materials, use online resources, and designate a "device champion" on your team.

Honestly, I'm not sure why some vendors provide excellent training while others treat it as an afterthought. My best guess is it comes down to corporate culture. But from a buyer's perspective, we can demand better. We can make training a line item in our contracts. We can ask for references from similar organizations. And we can share our own data on outcomes to justify the investment.

The Bottom Line

The medical device industry is evolving from selling products to delivering solutions. Companies like Coloplast are leading the way with comprehensive care programs, but every organization must adapt. The fundamentals—patient safety, clinical efficacy—remain. The execution, however, has transformed. Training matters. Period. Support matters. Integration matters. And if you're still buying devices like it's 2015, you're already behind.

What's your experience? Have you seen the shift toward integrated care? I'd love to hear how other healthcare organizations are handling this.